1.24 USD
+0.01 (+0.81%)
2.19 USD
+0.95 (+76.61%)
NCI gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 45 industry peers in the Textiles, Apparel & Luxury Goods industry. Both the profitability and the financial health of NCI get a neutral evaluation. Nothing too spectacular is happening here. NCI does not seem to be growing, but still is valued expensively.
1. Profitability
1.1 Basic Checks
NCI had positive earnings in the past year.
In the past year NCI had a positive cash flow from operations.
1.2 Ratios
NCI has a better Return On Assets (6.99%) than 82.22% of its industry peers.
The Return On Equity of NCI (16.68%) is better than 75.56% of its industry peers.
NCI has a better Return On Invested Capital (10.33%) than 73.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.99% | ||
| ROE | 16.68% | ||
| ROIC | 10.33% |
ROA(3y)13.48%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Profit Margin value of 3.01%, NCI perfoms like the industry average, outperforming 48.89% of the companies in the same industry.
In the last couple of years the Profit Margin of NCI has grown nicely.
NCI has a Operating Margin of 3.83%. This is in the lower half of the industry: NCI underperforms 60.00% of its industry peers.
In the last couple of years the Operating Margin of NCI has grown nicely.
Looking at the Gross Margin, with a value of 20.90%, NCI is doing worse than 84.44% of the companies in the same industry.
NCI's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 3.83% | ||
| PM (TTM) | 3.01% | ||
| GM | 20.9% |
OM growth 3Y38.21%
OM growth 5YN/A
PM growth 3Y14.72%
PM growth 5YN/A
GM growth 3Y30.72%
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so NCI is destroying value.
NCI has about the same amout of shares outstanding than it did 1 year ago.
Compared to 1 year ago, NCI has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.69 indicates that NCI is not a great score, but indicates only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 2.69, NCI is in line with its industry, outperforming 51.11% of the companies in the same industry.
There is no outstanding debt for NCI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 2.69 |
ROIC/WACC0.99
WACC10.39%
2.3 Liquidity
A Current Ratio of 1.84 indicates that NCI should not have too much problems paying its short term obligations.
NCI has a Current ratio of 1.84. This is comparable to the rest of the industry: NCI outperforms 42.22% of its industry peers.
A Quick Ratio of 1.75 indicates that NCI should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.75, NCI belongs to the top of the industry, outperforming 84.44% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.84 | ||
| Quick Ratio | 1.75 |
3. Growth
3.1 Past
NCI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 1423.08%, which is quite impressive.
NCI shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 15.35% yearly.
The Revenue has grown by 24.91% in the past year. This is a very strong growth!
The Revenue has been decreasing by -0.68% on average over the past years.
EPS 1Y (TTM)1423.08%
EPS 3Y15.35%
EPS 5YN/A
EPS Q2Q%89.32%
Revenue 1Y (TTM)24.91%
Revenue growth 3Y-0.68%
Revenue growth 5YN/A
Sales Q2Q%35.28%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 4.00 indicates a rather cheap valuation of NCI.
97.78% of the companies in the same industry are more expensive than NCI, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 26.76. NCI is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 4 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NCI indicates a rather cheap valuation: NCI is cheaper than 95.56% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 4.02 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for NCI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
1.24
+0.01 (+0.81%)
Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)
Earnings (Next)
Inst Owners0.08%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner Change0%
Market Cap5.03M
Revenue(TTM)314.92M
Net Income(TTM)9.48M
Analysts60
Price TargetN/A
Short Float %2.69%
Short Ratio0.46
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 4 | ||
| Fwd PE | N/A | ||
| P/S | 0.12 | ||
| P/FCF | N/A | ||
| P/OCF | 91.49 | ||
| P/B | 0.69 | ||
| P/tB | 0.91 | ||
| EV/EBITDA | 4.02 |
EPS(TTM)0.31
EY25%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.59
FCFYN/A
OCF(TTM)0.01
OCFY1.09%
SpS9.97
BVpS1.8
TBVpS1.37
PEG (NY)N/A
PEG (5Y)N/A
Graham Number3.54
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.99% | ||
| ROE | 16.68% | ||
| ROCE | 12.52% | ||
| ROIC | 10.33% | ||
| ROICexc | 11.41% | ||
| ROICexgc | 13.51% | ||
| OM | 3.83% | ||
| PM (TTM) | 3.01% | ||
| GM | 20.9% | ||
| FCFM | N/A |
ROA(3y)13.48%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)8.04%
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y38.21%
OM growth 5YN/A
PM growth 3Y14.72%
PM growth 5YN/A
GM growth 3Y30.72%
GM growth 5YN/A
F-Score6
Asset Turnover2.32
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 884.5% | ||
| Cap/Sales | 6.09% | ||
| Interest Coverage | 3.64 | ||
| Cash Conversion | 3.01% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.84 | ||
| Quick Ratio | 1.75 | ||
| Altman-Z | 2.69 |
F-Score6
WACC10.39%
ROIC/WACC0.99
Cap/Depr(3y)604.44%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.96%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)1423.08%
EPS 3Y15.35%
EPS 5YN/A
EPS Q2Q%89.32%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)24.91%
Revenue growth 3Y-0.68%
Revenue growth 5YN/A
Sales Q2Q%35.28%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y63.91%
EBIT growth 3Y37.27%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y62.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y100.87%
OCF growth 3Y-65.32%
OCF growth 5YN/A
NEO-CONCEPT INTL GROUP HLD-A / NCI FAQ
What is the fundamental rating for NCI stock?
ChartMill assigns a fundamental rating of 4 / 10 to NCI.
Can you provide the valuation status for NEO-CONCEPT INTL GROUP HLD-A?
ChartMill assigns a valuation rating of 3 / 10 to NEO-CONCEPT INTL GROUP HLD-A (NCI). This can be considered as Overvalued.
Can you provide the profitability details for NEO-CONCEPT INTL GROUP HLD-A?
NEO-CONCEPT INTL GROUP HLD-A (NCI) has a profitability rating of 4 / 10.
Can you provide the PE and PB ratios for NCI stock?
The Price/Earnings (PE) ratio for NEO-CONCEPT INTL GROUP HLD-A (NCI) is 4 and the Price/Book (PB) ratio is 0.69.
Can you provide the financial health for NCI stock?
The financial health rating of NEO-CONCEPT INTL GROUP HLD-A (NCI) is 6 / 10.